TY - JOUR
T1 - A year living with SARS-CoV-2
T2 - an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain)
AU - Andrés, Cristina
AU - Piñana, Maria
AU - Borràs-Bermejo, Blanca
AU - González-Sánchez, Alejandra
AU - García-Cehic, Damir
AU - Esperalba, Juliana
AU - Rando, Ariadna
AU - Zules-Oña, Ricardo Gabriel
AU - Campos, Carolina
AU - Codina, Maria Gema
AU - Blanco-Grau, Albert
AU - Colomer-Castell, Sergi
AU - Martín, Maria Carmen
AU - Castillo, Carla
AU - García-Comuñas, Karen
AU - Vásquez-Mercado, Rodrigo
AU - Martins-Martins, Reginaldo
AU - Saubi, Narcís
AU - Campins-Martí, Magda
AU - Pumarola, Tomàs
AU - Quer, Josep
AU - Antón, Andrés
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.
PY - 2022
Y1 - 2022
N2 - Herein, we describe the genetic diversity of circulating SARS-CoV-2 viruses by whole-genome sequencing (WGS) in Barcelona city (Catalonia, Spain) throughout the first four pandemic waves. From weeks 11/2020–24/2021, SARS-CoV-2-positive respiratory samples were randomly selected per clinical setting (80% from primary care or 20% from the hospital), age group, and week. WGS was performed following the ARTICv3 protocol on MiSeq or NextSeq2000 Illumina platforms. Nearly complete consensus sequences were used for genetic characterization based on GISAID and PANGOLIN nomenclatures. From 2475 samples, 2166 (87%) were fully sequenced (78% from primary care and 22% from hospital settings). Multiple genetic lineages were co-circulating, but four were predominant at different periods. While B.1.5 (50.68%) and B.1.1 (32.88%) were the major lineages during the first pandemic wave, B.1.177 (66.85%) and B.1.1.7 (83.80%) were predominant during the second, third, and fourth waves, respectively. Almost all (96.4%) were carrying D614G mutation in the S protein, with additional mutations that define lineages or variants. But some mutations of concern, such as E484K from B.1.351 and P.1 lineages are currently under monitoring, together with those observed in the receptor-binding domain or N-terminal domain, such as L452R and T478K from B.1.617.2 lineage. The fact that a predominant lineage was observed in each pandemic wave suggests advantageous properties over other contemporary co-circulating variants. This genetic variability should be monitored, especially when a massive vaccination campaign is ongoing because the potential selection and emergence of novel antigenic SARS-CoV-2 strains related to immunological escapement events.
AB - Herein, we describe the genetic diversity of circulating SARS-CoV-2 viruses by whole-genome sequencing (WGS) in Barcelona city (Catalonia, Spain) throughout the first four pandemic waves. From weeks 11/2020–24/2021, SARS-CoV-2-positive respiratory samples were randomly selected per clinical setting (80% from primary care or 20% from the hospital), age group, and week. WGS was performed following the ARTICv3 protocol on MiSeq or NextSeq2000 Illumina platforms. Nearly complete consensus sequences were used for genetic characterization based on GISAID and PANGOLIN nomenclatures. From 2475 samples, 2166 (87%) were fully sequenced (78% from primary care and 22% from hospital settings). Multiple genetic lineages were co-circulating, but four were predominant at different periods. While B.1.5 (50.68%) and B.1.1 (32.88%) were the major lineages during the first pandemic wave, B.1.177 (66.85%) and B.1.1.7 (83.80%) were predominant during the second, third, and fourth waves, respectively. Almost all (96.4%) were carrying D614G mutation in the S protein, with additional mutations that define lineages or variants. But some mutations of concern, such as E484K from B.1.351 and P.1 lineages are currently under monitoring, together with those observed in the receptor-binding domain or N-terminal domain, such as L452R and T478K from B.1.617.2 lineage. The fact that a predominant lineage was observed in each pandemic wave suggests advantageous properties over other contemporary co-circulating variants. This genetic variability should be monitored, especially when a massive vaccination campaign is ongoing because the potential selection and emergence of novel antigenic SARS-CoV-2 strains related to immunological escapement events.
KW - Catalonia
KW - COVID-19
KW - genetic diversity
KW - molecular epidemiology
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85122278556&partnerID=8YFLogxK
U2 - 10.1080/22221751.2021.2011617
DO - 10.1080/22221751.2021.2011617
M3 - Article
C2 - 34842496
AN - SCOPUS:85122278556
SN - 2222-1751
VL - 11
SP - 172
EP - 181
JO - Emerging Microbes and Infections
JF - Emerging Microbes and Infections
IS - 1
ER -